IKBKE, a prognostic factor preferentially expressed in...

Clinical and Translational Medicine 2020 / 07 Vol. 10; Iss. 3

IKBKE, a prognostic factor preferentially expressed in mesenchymal glioblastoma, modulates tumoral immunosuppression through the STAT3/PD‐L1 pathway

Yi, Li, Guo, Gaochao, Li, Jiabo, Fan, Xiaoguang, Li, Tao, Tong, Luqing, Liu, Peidong, Wang, Xuya, Yuan, Feng, Yu, Shengping, Huang, Qiang, Yang, Xuejun
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
10
Journal:
Clinical and Translational Medicine
DOI:
10.1002/ctm2.130
Date:
July, 2020
File:
PDF, 17.49 MB
2020
Conversion to is in progress
Conversion to is failed